Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

529.000
+39.2008.00%
Volume:31.41K
Turnover:15.78M
Market Cap:47.02B
PE:-630.49
High:537.000
Open:488.200
Low:463.000
Close:489.800
52wk High:765.500
52wk Low:178.000
Shares:88.88M
HK Float Shares:88.88M
Volume Ratio:0.72
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.839
ROE:-39.50%
ROA:-23.53%
PB:52.02
PE(LYR):-630.49
PS:219.93

Loading ...

Stock Track | DIAGENS-B Soars 5.60% Intraday on Strong Q1 Earnings Beat

Stock Track
·
Apr 20

Stock Track | DIAGENS-B Soars 6.24% Intraday on Strong Q1 Earnings and Positive Market Sentiment

Stock Track
·
Apr 16

Large Model Concept Stocks Show Strong Performance Before Noon, with DIAGENS-B and KNOWLEDGE ATLAS Both Rising Over 15%

Deep News
·
Apr 08

DIAGENS-B Shares Surge Over 7% on Strong AI Medical Imaging Foundation Model

Stock News
·
Apr 08

Diagens Issues FY2025 Results Notice; Full Annual Report to be Released by 30 April 2026

Bulletin Express
·
Mar 31

Medical Imaging AI Pioneer DIAGENS-B Soars 121% in Hong Kong IPO Debut

Deep News
·
Mar 30

Hangzhou Diagens Biotechnology Soars 121% in Hong Kong Trading Debut

MT Newswires Live
·
Mar 30

Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price

Stock Track
·
Mar 30

DIAGENS-B (02526) Debuts with 121.21% Surge in Early Trading, Focused on Medical Imaging AI Platform

Stock News
·
Mar 30

Shares of Shandong Extreme Vision Set to Open at HK$59.95 Each in Hong Kong Debut VS Offer Price HK$40 Apiece

THOMSON REUTERS
·
Mar 30

Diagens Biotechnology Raises HK$719.8 Million From Hong Kong IPO Ahead of Debut

MT Newswires Live
·
Mar 30

Hangzhou Diagens Biotechnology - Final Offer Price of HK$99.0 per H Share

THOMSON REUTERS
·
Mar 27

DIAGENS-B Soars Over 110% in Pre-Market Trading, Signaling Strong Debut for Medical AI Giant

Stock News
·
Mar 27

Unlisted Trading Shows DIAGENS-B (02526) Surging Over 87% at Opening, Generating HK$4,310 Per Lot

Stock News
·
Mar 27

Diagens Soared 82% In Hong Kong’s Grey Market Trading

MT Newswires Live
·
Mar 27

Hangzhou Diagens Biotechnology Defines Comprehensive Mandate for Board Nomination Committee Ahead of HKEX Listing

Bulletin Express
·
Mar 27

Diagens Updates Articles of Association in Preparation for Hong Kong H-Share Listing

Bulletin Express
·
Mar 27

Diagens Establishes Comprehensive Audit Committee Framework to Strengthen Financial Oversight

Bulletin Express
·
Mar 27

IPO Margin Financing Statistics as of March 24

Stock News
·
Mar 24

DIAGENS-B Poised to Lead Hong Kong IPO Pipeline Amid "Dream Valuation" Frenzy

Stock News
·
Mar 24